Revolution Medicines, Inc.
Total Trades
167
Buys
9
Sells
121
Largest Trade
N/A
Insiders
13
Institutional Funds
293
Inst. Value
$1M+
Activist Filings
40
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| GOLDSMITH MARK A | See Remarks | EXERCISE | $100K–$500K | 30K | $4.09 | Mar 4, 2026 |
| GOLDSMITH MARK A | See Remarks | GRANT | N/A | 57K | — | Mar 4, 2026 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 36K | $101.23 | Mar 4, 2026 |
| Cislini Jeff | General Counsel | SELL | $100K–$500K | 908 | $115.60 | Jan 23, 2026 |
| Horn Margaret A | COO | SELL | $1M+ | 75K | $100.56 | Jan 9, 2026 |
| Horn Margaret A | COO | EXERCISE | $1M+ | 75K | $38.47 | Jan 9, 2026 |
| Anders Jack | CFO | EXERCISE | $100K–$500K | 10K | $42.45 | Jan 9, 2026 |
| Anders Jack | CFO | SELL | $500K+ | 10K | $98.00 | Jan 9, 2026 |
| Cislini Jeff | General Counsel | SELL | $100K–$500K | 3K | $76.82 | Dec 18, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 15K | $76.82 | Dec 18, 2025 |
| Kelsey Stephen Michael | See Remarks | SELL | $100K–$500K | 5K | $76.82 | Dec 18, 2025 |
| Horn Margaret A | COO | SELL | $100K–$500K | 5K | $76.82 | Dec 18, 2025 |
| Anders Jack | CFO | SELL | $100K–$500K | 3K | $77.09 | Dec 18, 2025 |
| Anders Jack | CFO | SELL | $100K–$500K | 5K | $74.00 | Nov 26, 2025 |
| Anders Jack | CFO | EXERCISE | $50K–$100K | 5K | $17.00 | Nov 26, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 66K | $75.08 | Nov 26, 2025 |
| GOLDSMITH MARK A | See Remarks | EXERCISE | $100K–$500K | 60K | $4.09 | Nov 26, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 20K | $70.38 | Nov 20, 2025 |
| GOLDSMITH MARK A | See Remarks | EXERCISE | $50K–$100K | 20K | $4.09 | Nov 20, 2025 |
| Cislini Jeff | General Counsel | EXERCISE | $500K+ | 13K | $42.45 | Nov 20, 2025 |
| Cislini Jeff | General Counsel | SELL | $500K+ | 13K | $70.14 | Nov 20, 2025 |
| GOLDSMITH MARK A | See Remarks | EXERCISE | $50K–$100K | 20K | $4.09 | Nov 15, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 20K | $65.07 | Nov 15, 2025 |
| Anders Jack | CFO | EXERCISE | $100K–$500K | 10K | $17.00 | Nov 13, 2025 |
| Anders Jack | CFO | SELL | $500K+ | 10K | $64.00 | Nov 13, 2025 |
| GOLDSMITH MARK A | See Remarks | EXERCISE | $15K–$50K | 30K | $1.47 | Nov 13, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 30K | $60.31 | Nov 13, 2025 |
| Cislini Jeff | General Counsel | SELL | $500K+ | 12K | $55.00 | Oct 20, 2025 |
| Cislini Jeff | General Counsel | EXERCISE | $100K–$500K | 12K | $36.57 | Oct 20, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $1M+ | 20K | $52.74 | Oct 20, 2025 |
| GOLDSMITH MARK A | See Remarks | EXERCISE | $15K–$50K | 20K | $1.12 | Oct 20, 2025 |
| Cislini Jeff | General Counsel | SELL | $50K–$100K | 2K | $44.26 | Sep 26, 2025 |
| Wei Lin | Chief Medical Offi… | SELL | $50K–$100K | 2K | $45.82 | Sep 18, 2025 |
| Kelsey Stephen Michael | See Remarks | SELL | $100K–$500K | 5K | $45.82 | Sep 18, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $500K+ | 13K | $45.82 | Sep 18, 2025 |
| Horn Margaret A | COO | SELL | $100K–$500K | 5K | $45.82 | Sep 18, 2025 |
| Cislini Jeff | General Counsel | SELL | $50K–$100K | 2K | $45.82 | Sep 18, 2025 |
| Anders Jack | CFO | SELL | $100K–$500K | 2K | $45.82 | Sep 18, 2025 |
| Kelsey Stephen Michael | See Remarks | SELL | $1M+ | 125K | $44.46 | Sep 16, 2025 |
| Kelsey Stephen Michael | See Remarks | EXERCISE | $500K+ | 125K | $4.73 | Sep 16, 2025 |
| Anders Jack | CFO | EXERCISE | $50K–$100K | 10K | $6.67 | Sep 4, 2025 |
| Anders Jack | CFO | SELL | $100K–$500K | 10K | $40.10 | Sep 4, 2025 |
| Cislini Jeff | General Counsel | SELL | $50K–$100K | 2K | $39.61 | Jun 23, 2025 |
| Horn Margaret A | COO | SELL | $100K–$500K | 4K | $39.83 | Jun 18, 2025 |
| GOLDSMITH MARK A | See Remarks | SELL | $500K+ | 13K | $39.83 | Jun 18, 2025 |
| Cislini Jeff | General Counsel | SELL | $50K–$100K | 2K | $39.83 | Jun 18, 2025 |
| Anders Jack | CFO | SELL | $50K–$100K | 2K | $39.83 | Jun 18, 2025 |
| Kelsey Stephen Michael | See Remarks | SELL | $100K–$500K | 4K | $39.83 | Jun 18, 2025 |
| Wei Lin | Chief Medical Offi… | SELL | $50K–$100K | 2K | $39.83 | Jun 18, 2025 |
| Cislini Jeff | General Counsel | SELL | $50K–$100K | 2K | $38.71 | Mar 24, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 293 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Nextech Invest, Ltd. | 7.6M | $1M+ | SH |
| STATE STREET CORP | 4.1M | $1M+ | SH |
| Alphabet Inc. | 3.3M | $1M+ | SH |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.8M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $1M+ | SH |
| NORGES BANK | 2.5M | $1M+ | SH |
| Lunate Capital Ltd | 2.2M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.7M | $1M+ | SH |
| Siren, L.L.C. | 1.3M | $1M+ | SH |
| Caligan Partners LP | 1.3M | $1M+ | SH |
| Jefferies Financial Group Inc. | 1.1M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.1M | $1M+ | SH |
| Candriam S.C.A. | 1.0M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.0M | $1M+ | SH |
| Logos Global Management LP | 1.0M | $1M+ | SH (Call) |
| a16z Capital Management, L.L.C. | 921K | $1M+ | SH |
| AIHC Capital Management Ltd | 900K | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 797K | $1M+ | SH |
| First Turn Management, LLC | 638K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 619K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
4.9%
9.5M shares
Wellington Management Group LLP
SC 13G/A · Feb 10, 2026
3.6%
7.0M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 9, 2026
0.5%
1.1M shares
SC 13G/A · Nov 14, 2025
6.1%
11.4M shares
SC 13G · Nov 5, 2025
5.0%
9.4M shares
SC 13G · Aug 14, 2025
5.0%
9.4M shares
SC 13G/A · Aug 14, 2025
5.7%
10.6M shares
Wellington Management Group LLP
SC 13G/A · Aug 12, 2025
5.5%
10.3M shares
SC 13G/A · Jul 17, 2025
4.5%
8.4M shares
Farallon Capital Partners, L.P.
SC 13G/A · May 15, 2025
0.5%
895K shares
Farallon Capital Partners, L.P.
SC 13G/A · May 15, 2025
0.5%
817K shares
Farallon Capital Partners, L.P.
SC 13G · May 15, 2025
0.3%
441K shares
SC 13G/A · May 14, 2025
5.5%
10.2M shares
SC 13G · Feb 14, 2025
5.2%
9.5M shares
Wellington Management Group LLP
SC 13G/A · Nov 8, 2024
6.8%
11.4M shares
SC 13G/A · Feb 14, 2024
0.1%
133K shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
1.9%
3.1M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.9%
14.6M shares
SC 13G/A · Feb 13, 2024
3.1%
5.0M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 12, 2024
0.2%
330K shares
SC 13G/A · Feb 9, 2024
0.0%
0 shares
SC 13G/A · Jan 26, 2024
7.9%
13.0M shares
Farallon Capital Partners, L.P.
SC 13G · Nov 9, 2023
0.3%
292K shares
Wellington Management Group LLP
SC 13G/A · Nov 9, 2023
13.0%
14.2M shares
Biotechnology Value Fund, L.P.
SC 13G · Jun 30, 2023
4.4%
4.6M shares
SC 13G/A · Jun 16, 2023
6.8%
7.2M shares
SC 13G/A · Feb 14, 2023
5.4%
4.8M shares
SC 13G/A · Feb 14, 2023
1.8%
1.6M shares
SC 13G/A · Feb 13, 2023
1.8%
1.6M shares
SC 13G/A · Jan 31, 2023
7.4%
6.6M shares
SC 13G · Jan 23, 2023
5.0%
4.5M shares
Wellington Management Group LLP
SC 13G/A · Dec 9, 2022
10.1%
8.9M shares
SC 13G · Sep 29, 2022
5.2%
4.6M shares
SC 13G · Jun 27, 2022
5.8%
4.3M shares
SC 13G/A · May 10, 2022
0.3%
186K shares
SC 13G/A · Feb 14, 2022
7.5%
5.5M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
1.2%
887K shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 12, 2022
1.3%
965K shares
SC 13G/A · Feb 11, 2022
2.1%
1.6M shares
SC 13G/A · Jan 10, 2022
8.3%
6.1M shares